{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:21Z","timestamp":1788812001368,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-026-00245-7","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:10:10Z","timestamp":1788768610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive analysis of lung cancer status changes over 10 years: results of Moroccan cohort"],"prefix":"10.1038","volume":"4","author":[{"given":"Hassan Abdelilah","family":"Tafenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef AIT","family":"Takniouine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Essadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhizlane","family":"Belbaraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"245_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10552-009-9300-8","volume":"20","author":"A Sidorchuk","year":"2009","unstructured":"Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control. 2009;20:459\u201371. https:\/\/doi.org\/10.1007\/s10552-009-9300-8.","journal-title":"Cancer Causes Control"},{"key":"245_CR2","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/cncr.34327","volume":"128","author":"A Gupta","year":"2022","unstructured":"Gupta A, Omeogu CH, Islam JY, Joshi AR, Akinyemiju TF. Association of area-level socioeconomic status and non-small cell lung cancer stage by race\/ethnicity and health care-level factors: analysis of the National Cancer Database. Cancer. 2022;128:3099\u2013108. https:\/\/doi.org\/10.1002\/cncr.34327.","journal-title":"Cancer"},{"key":"245_CR3","doi-asserted-by":"publisher","first-page":"e0192999","DOI":"10.1371\/journal.pone.0192999","volume":"13","author":"J Hovanec","year":"2018","unstructured":"Hovanec J, Siemiatycki J, Conway DI, Olsson A, St\u00fccker I, Guida F, et al. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PloS One. 2018;13:e0192999 https:\/\/doi.org\/10.1371\/journal.pone.0192999.","journal-title":"PloS One"},{"key":"245_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339. https:\/\/doi.org\/10.1038\/s41571-023-00798-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"245_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"245_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/bjc.1955.55","volume":"9","author":"RH Thomlinson","year":"1955","unstructured":"Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9:539\u201349. https:\/\/doi.org\/10.1038\/bjc.1955.55.","journal-title":"Br J Cancer"},{"key":"245_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/jnci\/djab192","volume":"113","author":"KR Yabroff","year":"2021","unstructured":"Yabroff KR, Mariotto A, Tangka F, Zhao J, Islami F, Sung H, et al. Annual report to the nation on the status of cancer, part 2: patient economic burden associated with cancer care. J Natl Cancer Inst. 2021;113:1670\u201382. https:\/\/doi.org\/10.1093\/jnci\/djab192.","journal-title":"J Natl Cancer Inst"},{"key":"245_CR8","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/ijc.34217","volume":"151","author":"F Islami","year":"2022","unstructured":"Islami F, Marlow EC, Zhao J, Wiese D, Asare S, Bandi P, et al. Person-years of life lost and lost earnings from cigarette smoking-attributable cancer deaths, United States, 2019. Int J Cancer. 2022;151:2095\u2013106. https:\/\/doi.org\/10.1002\/ijc.34217.","journal-title":"Int J Cancer"},{"key":"245_CR9","doi-asserted-by":"publisher","unstructured":"Tafenzi HA, Essadi I, Belbaraka R. Lung cancer in Morocco. J Thorac Oncol. 2026;21. https:\/\/doi.org\/10.1016\/j.jtho.2026.103561.","DOI":"10.1016\/j.jtho.2026.103561"},{"key":"245_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11355-7","volume":"23","author":"HA Tafenzi","year":"2023","unstructured":"Tafenzi HA, Choulli F, Adjade G, Baladi A, Afani L, Fadli ME, et al. Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort. BMC Cancer. 2023;23:1016. https:\/\/doi.org\/10.1186\/s12885-023-11355-7.","journal-title":"BMC Cancer"},{"key":"245_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1378\/chest.10-1099","volume":"139","author":"O Lababede","year":"2011","unstructured":"Lababede O, Meziane M, Rice T. Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. CHEST. 2011;139:183\u20139. https:\/\/doi.org\/10.1378\/chest.10-1099.","journal-title":"CHEST"},{"key":"245_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1634\/theoncologist.2017-0659","volume":"23","author":"O Lababede","year":"2018","unstructured":"Lababede O, Meziane MA. The eighth edition of TNM staging of lung cancer: reference chart and diagrams. Oncologist. 2018;23:844\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2017-0659.","journal-title":"Oncologist"},{"key":"245_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19:1007\u201327. https:\/\/doi.org\/10.1016\/j.jtho.2024.02.011.","journal-title":"J Thorac Oncol"},{"key":"245_CR14","doi-asserted-by":"publisher","unstructured":"Beasley MB, Brambilla E, Travis WD The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;Lung Cancer40:90\u20137. https:\/\/doi.org\/10.1053\/j.ro.2005.01.001.","DOI":"10.1053\/j.ro.2005.01.001"},{"key":"245_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243\u201360. https:\/\/doi.org\/10.1097\/JTO.0000000000000630.","journal-title":"J Thorac Oncol"},{"key":"245_CR16","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jtho.2019.02.016","volume":"14","author":"AR Jazieh","year":"2019","unstructured":"Jazieh AR, Algwaiz G, Errihani H, Elghissassi I, Mula-Hussain L, Bawazir AA, et al. Lung cancer in the Middle East and North Africa Region. J Thorac Oncol. 2019;14:1884\u201391. https:\/\/doi.org\/10.1016\/j.jtho.2019.02.016.","journal-title":"J Thorac Oncol"},{"key":"245_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ejca.2013.10.014","volume":"51","author":"J Lortet-Tieulent","year":"2015","unstructured":"Lortet-Tieulent J, Renteria E, Sharp L, Weiderpass E, Comber H, Baas P, et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988\u20132010. Eur J Cancer. 2015;51:1144\u201363. https:\/\/doi.org\/10.1016\/j.ejca.2013.10.014.","journal-title":"Eur J Cancer"},{"key":"245_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","volume":"28","author":"MB Schabath","year":"2019","unstructured":"Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomark Prev. 2019;28:1563\u201379. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0221.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"245_CR19","doi-asserted-by":"publisher","unstructured":"Fink H, Langselius O, Vignat J, Rumgay H, Rehm J, Martinez RX, et al. Global and regional cancer burden attributable to modifiable risk factors to inform prevention. Nat Med. 2026;1\u201310. https:\/\/doi.org\/10.1038\/s41591-026-04219-7.","DOI":"10.1038\/s41591-026-04219-7"},{"key":"245_CR20","doi-asserted-by":"publisher","unstructured":"Martinasek MP, McGrogan JB, Maysonet A. A systematic review of the respiratory effects of inhalational marijuana. Respir Care. 2016;61:1543\u201351. https:\/\/doi.org\/10.4187\/respcare.04846.","DOI":"10.4187\/respcare.04846"},{"key":"245_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.oraloncology.2011.05.004","volume":"47","author":"D Anantharaman","year":"2011","unstructured":"Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H, et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol. 2011;47:725\u201331. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.05.004.","journal-title":"Oral Oncol"},{"key":"245_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jtho.2017.12.013","volume":"13","author":"J Jett","year":"2018","unstructured":"Jett J, Stone E, Warren G, Cummings KM. Cannabis use, lung cancer, and related issues. J Thorac Oncol. 2018;13:480\u20137. https:\/\/doi.org\/10.1016\/j.jtho.2017.12.013.","journal-title":"J Thorac Oncol"},{"key":"245_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107971","volume":"198","author":"R Chen","year":"2024","unstructured":"Chen R, Donlon TA, Morris BJ, Allsopp RC, Willcox BJ, Masaki KH. Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer. 2024;198:107971. https:\/\/doi.org\/10.1016\/j.lungcan.2024.107971.","journal-title":"Lung Cancer"},{"key":"245_CR24","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/annonc\/mdr027","volume":"22","author":"V Bagnardi","year":"2011","unstructured":"Bagnardi V, Rota M, Botteri E, Scotti L, Jenab M, Bellocco R, et al. Alcohol consumption and lung cancer risk in never smokers: a meta-analysis. Ann Oncol. 2011;22:2631\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdr027.","journal-title":"Ann Oncol"},{"key":"245_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ijc.29036","volume":"136","author":"LR Zhang","year":"2015","unstructured":"Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, et al. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136:894\u2013903. https:\/\/doi.org\/10.1002\/ijc.29036.","journal-title":"Int J Cancer"},{"key":"245_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jtho.2022.12.007","volume":"18","author":"MS Frank","year":"2023","unstructured":"Frank MS, Bodtger U. An individualized approach to comorbidities in lung cancer. J Thorac Oncol. 2023;18:254\u20136. https:\/\/doi.org\/10.1016\/j.jtho.2022.12.007.","journal-title":"J Thorac Oncol"},{"key":"245_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7:391 https:\/\/doi.org\/10.1038\/s41392-022-01251-0.","journal-title":"Signal Transduct Target Ther"},{"key":"245_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000354173","volume":"59","author":"R Shaykhiev","year":"2013","unstructured":"Shaykhiev R, Crystal RG. Innate immunity and chronic obstructive pulmonary disease: a mini-review. Gerontology. 2013;59:481\u20139. https:\/\/doi.org\/10.1159\/000354173.","journal-title":"Gerontology"},{"key":"245_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5603\/PiAP.2016.0022","volume":"84","author":"AE Dutkowska","year":"2016","unstructured":"Dutkowska AE, Antczak A. Comorbidities in lung cancer. Pneumonol Alergol Pol. 2016;84:186\u201392. https:\/\/doi.org\/10.5603\/PiAP.2016.0022.","journal-title":"Pneumonol Alergol Pol"},{"key":"245_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1252897","volume":"2018","author":"S Dima","year":"2018","unstructured":"Dima S, Chen KH, Wang KJ, Wang KM, Teng NC. Effect of comorbidity on lung cancer diagnosis timing and mortality: a nationwide population-based cohort study in Taiwan. BioMed Res Int. 2018;2018:1252897. https:\/\/doi.org\/10.1155\/2018\/1252897.","journal-title":"BioMed Res Int"},{"key":"245_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03139-5","volume":"11","author":"H Ajimizu","year":"2021","unstructured":"Ajimizu H, Ozasa H, Sato S, Funazo T, Sakamori Y, Nomizo T, et al. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer. Sci Rep. 2021;11:23677. https:\/\/doi.org\/10.1038\/s41598-021-03139-5.","journal-title":"Sci Rep"},{"key":"245_CR32","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607 https:\/\/doi.org\/10.1136\/bmj.g7607.","journal-title":"BMJ"},{"key":"245_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-024-01308-w","volume":"16","author":"J Liu","year":"2024","unstructured":"Liu J, Wang R, Tan S, Zhao X, Hou A. Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis. Diabetol Metab Syndr. 2024;16:63 https:\/\/doi.org\/10.1186\/s13098-024-01308-w.","journal-title":"Diabetol Metab Syndr"},{"key":"245_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.lungcan.2015.01.006","volume":"88","author":"J Kravchenko","year":"2015","unstructured":"Kravchenko J, Berry M, Arbeev K, Lyerly HK, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer Amst Neth. 2015;88:85\u201393. https:\/\/doi.org\/10.1016\/j.lungcan.2015.01.006.","journal-title":"Lung Cancer Amst Neth"},{"key":"245_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1258991","volume":"14","author":"M de Jesus","year":"2024","unstructured":"de Jesus M, Chanda A, Grabauskas T, Kumar M, Kim AS. Cardiovascular disease and lung cancer. Front Oncol. 2024;14:1258991. https:\/\/doi.org\/10.3389\/fonc.2024.1258991.","journal-title":"Front Oncol"},{"key":"245_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14336\/AD.2016.0627","volume":"8","author":"H Zheng","year":"2017","unstructured":"Zheng H, Wu J, Jin Z, Yan LJ. Potential biochemical mechanisms of lung injury in diabetes. Aging Dis. 2017;8:7\u201316. https:\/\/doi.org\/10.14336\/AD.2016.0627.","journal-title":"Aging Dis"},{"key":"245_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1900475","volume":"381","author":"A Agust\u00ed","year":"2019","unstructured":"Agust\u00ed A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381:1248\u201356. https:\/\/doi.org\/10.1056\/NEJMra1900475.","journal-title":"N Engl J Med"},{"key":"245_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-025-00417-x","volume":"35","author":"STY Yau","year":"2025","unstructured":"Yau STY, Hung CT, Leung EYM, Lee A, Yeoh EK. The interactions among factors associated with the risk of lung cancer among diabetes patients: a survival tree analysis. Npj Prim Care Respir Med. 2025;35:1\u20136. https:\/\/doi.org\/10.1038\/s41533-025-00417-x.","journal-title":"Npj Prim Care Respir Med"},{"key":"245_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05538-4","volume":"22","author":"F Citarella","year":"2024","unstructured":"Citarella F, Takada K, Cascetta P, Crucitti P, Petti R, Vincenzi B, et al. Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional\/prospective study design (FAHIC: lung). J Transl Med. 2024;22:714. https:\/\/doi.org\/10.1186\/s12967-024-05538-4.","journal-title":"J Transl Med"},{"key":"245_CR40","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/sj.bjc.6603386","volume":"95","author":"A Cassidy","year":"2006","unstructured":"Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK. Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. Br J Cancer. 2006;95:1288\u201390. https:\/\/doi.org\/10.1038\/sj.bjc.6603386.","journal-title":"Br J Cancer"},{"key":"245_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.lungcan.2020.08.012","volume":"148","author":"L Ang","year":"2020","unstructured":"Ang L, Chan CPY, Yau WP, Seow WJ. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis. Lung Cancer. 2020;148:129\u201337. https:\/\/doi.org\/10.1016\/j.lungcan.2020.08.012.","journal-title":"Lung Cancer"},{"key":"245_CR42","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jtho.2019.04.019","volume":"14","author":"LA Cannon-Albright","year":"2019","unstructured":"Cannon-Albright LA, Carr SR, Akerley W. Population-based relative risks for lung cancer based on complete family history of lung cancer. J Thorac Oncol. 2019;14:1184\u201391. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.019.","journal-title":"J Thorac Oncol"},{"key":"245_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001021","volume":"5","author":"A Ruano-Ravi\u00f1a","year":"2020","unstructured":"Ruano-Ravi\u00f1a A, Provencio M, Calvo de Juan V, Carcereny E, Moran T, Rodriguez-Abreu D, et al. Lung cancer symptoms at diagnosis: results of a nationwide registry study. ESMO Open. 2020;5:e001021. https:\/\/doi.org\/10.1136\/esmoopen-2020-001021.","journal-title":"ESMO Open"},{"key":"245_CR44","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/thoraxjnl-2018-211596","volume":"73","author":"VL Athey","year":"2018","unstructured":"Athey VL, Walters SJ, Rogers TK. Symptoms at lung cancer diagnosis are associated with major differences in prognosis. Thorax. 2018;73:1177\u201381. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211596.","journal-title":"Thorax"},{"key":"245_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0169-5002(01)00451-2","volume":"36","author":"H Koyi","year":"2002","unstructured":"Koyi H, Hillerdal G, Brand\u00e9n E. A prospective study of a total material of lung cancer from a county in Sweden 1997\u20131999: gender, symptoms, type, stage, and smoking habits. Lung Cancer. 2002;36:9\u201314. https:\/\/doi.org\/10.1016\/S0169-5002(01)00451-2.","journal-title":"Lung Cancer"},{"key":"245_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canep.2019.04.014","volume":"60","author":"G Kourlaba","year":"2019","unstructured":"Kourlaba G, Gkiozos I, Kokkotou E, Stefanou G, Papaspiliou A, Syrigos K. Lung cancer patients\u2019 journey from first symptom to treatment: Results from a Greek registry. Cancer Epidemiol. 2019;60:193\u2013200. https:\/\/doi.org\/10.1016\/j.canep.2019.04.014.","journal-title":"Cancer Epidemiol"},{"key":"245_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-025-00412-2","volume":"35","author":"LMS S\u00e6tre","year":"2025","unstructured":"S\u00e6tre LMS, Balasubramaniam K, S\u00f8ndergaard J, Jarb\u00f8l DE. Smoking status, symptom significance and healthcare seeking with lung cancer symptoms in the Danish general population. Npj Prim Care Respir Med. 2025;35:1\u201312. https:\/\/doi.org\/10.1038\/s41533-025-00412-2.","journal-title":"Npj Prim Care Respir Med"},{"key":"245_CR48","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1002\/cam4.2256","volume":"8","author":"P Xing","year":"2019","unstructured":"Xing P, Zhu Y, Wang L, Hui Z, Liu S, Ren J, et al. What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China. Cancer Med. 2019;8:4055\u201369. https:\/\/doi.org\/10.1002\/cam4.2256.","journal-title":"Cancer Med"},{"key":"245_CR49","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, et al. Lung cancer statistics, 2023. Cancer. 2024;130:1330\u201348. https:\/\/doi.org\/10.1002\/cncr.35128.","journal-title":"Cancer"},{"key":"245_CR50","doi-asserted-by":"publisher","unstructured":"Debieuvre D, Molinier O, Falchero L, Locher C, Templement-Grangerat D, Meyer N, et al. Lung cancer trends and tumor characteristic changes over 20 years (2000\u20132020): Results of three French consecutive nationwide prospective cohorts\u2019 studies. Lancet Reg Health\u2014Eur. 2022;22. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100492.","DOI":"10.1016\/j.lanepe.2022.100492"},{"key":"245_CR51","doi-asserted-by":"publisher","unstructured":"Ruano-Ravina A, Provencio M, Juan VC de, Carcereny E, Estival A, et al. Are there differences by sex in lung cancer characteristics at diagnosis? \u2014a nationwide study. Transl Lung Cancer Res. 2021;10. https:\/\/doi.org\/10.21037\/tlcr-21-559","DOI":"10.21037\/tlcr-21-559"},{"key":"245_CR52","doi-asserted-by":"publisher","unstructured":"Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, et al. Uniqueness of lung cancer in Southeast Asia. Lancet Reg Health\u2014Southeast Asia. 2024;27. https:\/\/doi.org\/10.1016\/j.lansea.2024.100430.","DOI":"10.1016\/j.lansea.2024.100430"},{"key":"245_CR53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","volume":"36","author":"A Zer","year":"2025","unstructured":"Zer A, Ahn MJ, Barlesi F, Bubendorf L, Ruysscher DD, Garrido P, et al. Early and locally advanced non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2025;36:1245\u201362. https:\/\/doi.org\/10.1016\/j.annonc.2025.08.003.","journal-title":"Ann Oncol"},{"key":"245_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2023;34:358\u201376. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.013.","journal-title":"Ann Oncol"},{"key":"245_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2023;34:339\u201357. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.009.","journal-title":"Ann Oncol"},{"key":"245_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO-25-02822","volume":"0","author":"S Puri","year":"2026","unstructured":"Puri S, Leighl NB, Ismaila N, Rous FA, Ahluwalia A, Alluri K, et al. Therapy for stage IV non\u2013small cell lung cancer with driver alterations: ASCO living guideline, 2026.3.0. J Clin Oncol. 2026;0:25\u201302822. https:\/\/doi.org\/10.1200\/JCO-25-02822.","journal-title":"J Clin Oncol"},{"key":"245_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO-25-02825","volume":"0","author":"JE Reuss","year":"2026","unstructured":"Reuss JE, Bazhenova L, Ismaila N, Abu Rous F, Ahluwalia A, Alluri K, et al. Therapy for stage IV non\u2013small cell lung cancer without driver alterations: ASCO living guideline, 2026.3.0. J Clin Oncol. 2026;0:25\u201302825. https:\/\/doi.org\/10.1200\/JCO-25-02825.","journal-title":"J Clin Oncol"},{"key":"245_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1200\/OP-24-00784","volume":"21","author":"N Singh","year":"2025","unstructured":"Singh N, Fr\u00fch M, Gubens MA, Ismaila N, Daly ME. Management of stage III non\u2013small cell lung cancer: ASCO guideline rapid recommendation update clinical insights. JCO Oncol Pract. 2025;21:463\u20136. https:\/\/doi.org\/10.1200\/OP-24-00784.","journal-title":"JCO Oncol Pract"},{"key":"245_CR59","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1200\/JCO.22.00051","volume":"40","author":"K Pisters","year":"2022","unstructured":"Pisters K, Kris MG, Gaspar LE, Ismaila N. for the Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA NSCLC Guideline Expert Panel. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non\u2013Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2022;40:1127\u20139. https:\/\/doi.org\/10.1200\/JCO.22.00051.","journal-title":"J Clin Oncol"},{"key":"245_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1489327","volume":"15","author":"HA Tafenzi","year":"2025","unstructured":"Tafenzi HA, Choulli F, Essadi I, Belbaraka R. Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study. Front Oncol. 2025;15:1489327. https:\/\/doi.org\/10.3389\/fonc.2025.1489327.","journal-title":"Front Oncol"},{"key":"245_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"245_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"National Lung Screening Trial Resea","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873.","journal-title":"N Engl J Med"},{"key":"245_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100179","volume":"10","author":"JK Field","year":"2021","unstructured":"Field JK, Vulkan D, Davies MPA, Baldwin DR, Brain KE, Devaraj A, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur. 2021;10:100179. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100179.","journal-title":"Lancet Reg Health Eur"},{"key":"245_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102015","volume":"47","author":"HA Tafenzi","year":"2024","unstructured":"Tafenzi HA, Choulli F, Haag EK, Baladi A, Essaadi I, Belbaraka R. Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort. Transl Oncol. 2024;47:102015. https:\/\/doi.org\/10.1016\/j.tranon.2024.102015.","journal-title":"Transl Oncol"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00245-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00245-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00245-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:03:03Z","timestamp":1788811383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00245-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1038\/s44276-026-00245-7","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors affirm responsibility for all aspects of this work and have ensured that any concerns related to data integrity or scientific accuracy have been appropriately addressed. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki (revised 2013). Approval for data access and study conduct was obtained from the Ethical Review Committee of the Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco. All patient records were anonymised prior to analysis to preserve confidentiality and comply with ethical standards for retrospective research. As this study involved secondary use of archival clinical data and posed minimal risk to participants, informed consent was not required. This waiver was granted in accordance with Moroccan Law No. 28-13 on the Protection of Persons Participating in Biomedical Research, which permits the use of anonymised patient data for non-interventional, retrospective studies conducted within public academic institutions. Furthermore, when patients or family members were contacted to fill gaps in documentation, verbal consent was obtained after clearly explaining the purpose of the data collection. Individuals retained the right to decline participation, aligning with both national regulatory guidance and the ethical principles of autonomy and transparency.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"45"}}